FDA DTC Study Aims To Fool Consumers, But Not Doctors, In Use Of Fictitious Drug
This article was originally published in The Pink Sheet Daily
Executive Summary
Study examining design of print advertisements will be straightforward with doctors that a fictitious drug is being presented, while the wording for consumers will be ambiguous.
You may also be interested in...
FDA's Advertising Studies Expand To Internet Spots, Disease Awareness
FDA is continuing to start new studies on the format of advertising even as it prepares to release the results from previous research. While the steady drip of studies gives industry continuing opportunity to provide feedback to the agency's Division of Drug Marketing, Advertising and Communications, it also means that the findings that FDA makes, particularly on the impact of qualitative language, may be superseded by further research.